BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, September 20, 2024
See today's BioWorld
Home
» Other news to note for March 15, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 15, 2021
March 15, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Aeterna Zentaris, Altimmune, Amring, Amzell, Aveo, Astrazeneca, Biovaxys, Bright Minds, Decipher, Destiny, Genevant, Gilead, Horizon, J&J, Lattice, Magenta, Merck, Mersana, Newron, Point, PTC, Resverlogix, Takeda, Tevogen, Timber, Urogen, Veracyte, Viela, Wuxi, Zambon.
BioWorld
Briefs
Other news to note
Coronavirus